| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Nimodipine | Cerebonal Tablets (Nimodipine) | Film-coated tablet | Supply Discontinuation | 2026-01-05 |
| Nalbuphine Hydrochloride | Nalbuphine Hydrochloride Injection 10 Milligrams | Solution for Injection | Supply Discontinuation | 2026-01-05 |
| Active ingredients |
| Date of last message | Type of reason | AM designation | |
| Human fibrinogen | Change notification | 11.01.2026 | Other | FibCLOT | |
| Trimipramine mesylate | Change notification | 09.01.2026 | Other | Trimipramine – 1 A Pharma 40 mg/ml oral drops, solution | |
| Etoposide phosphate | Initial report | 09.01.2026 | Production problem | Etopophos 1000 mg, powder for solution for infusion | |
| Vandetanib | Initial report | 09.01.2026 | Other | Caprelsa 300 mg film-coated tablets – OP30 | |
| Phenobarbital sodium | Initial report | 09.01.2026 | Other | Luminal solution for injection | |
| Levetiracetam | Initial report | 09.01.2026 | Other | Keppra 100 mg/ml oral solution – OP (1x150ml) | |
| Morphine hemisulfate 2.5 hydrate | Initial report | 09.01.2026 | Production problem | Substitol 60 mg hard capsule, delayed release | |
| Erythromycin lactobionate | Initial report | 09.01.2026 | Production problem | Erythromycin Inresa i.v. 1g | |
| Lidocaine hydrochloride monohydrate | Change notification | 09.01.2026 | Other | Xylocaine Gel 2% | |
| Mometasone furoate (Ph.Eur.) | Initial report | 09.01.2026 | Production problem | Momecutan solution | |
| Insulin aspart | Initial report | 09.01.2026 | Other | NovoRapid 100 E/ml solution for injection in vial – OP[5x(1x10ml)] | |
| Pramipexole dihydrochloride monohydrate | Change notification | 09.01.2026 | Other | Pramipexole – 1 A Pharma 0.26 mg prolonged-release tablets | |
| Aprepitant | Change notification | 09.01.2026 | Other | EMEND 125 mg powder for oral suspension – OPXXXXmg | |
| Oxytocin | Change notification | 09.01.2026 | Production problem | Oxytocin 3 IU Hexal | |
| Metamizole sodium monohydrate | Change notification | 09.01.2026 | Production problem | Novaminsulfon – 1 A Pharma Drops | |
| Digoxin | Change notification | 08.01.2026 | Production problem | Lanicor | |
| Methylprednisolone | Change notification | 08.01.2026 | Production problem | Urbason 16 mg tablets | |
| (RS)-2,3-Bis(sulfanyl)propane-1-sulfonic acid sodium salt monohydrate | Initial report | 08.01.2026 | Production problem | Dimaval | |
| Epoetin theta | Initial report | 08.01.2026 | Other | Eporatio 5000 IU/0.5 ml injection solution in pre-filled syringe – OP (6×0.5 ml) | |
| Insulin aspart | Change notification | 08.01.2026 | Other | Kirsty 100 units/ml solution for injection in a pre-filled pen | |
| Insulin aspart | Change notification | 08.01.2026 | Other | Kirsty 100 units/ml solution for injection in a pre-filled pen | |
| Doxycycline monohydrate | Initial report | 08.01.2026 | Other | Doxycycline AL 200 | |
| Dinoprostone | Initial report | 08.01.2026 | Other | Prepidil Gel | |
| Fusidic acid (Ph.Eur.) | Change notification | 08.01.2026 | Production problem | Fucithalmic 10 mg/g eye drops | |
| Indomethacin | Initial report | 08.01.2026 | Other | Indomethacin AL 50 | |
| Oxycodone hydrochloride (Ph.Eur.) | Change notification | 08.01.2026 | Production problem | Oxygesic injection 10 mg/ml | |
| Lanreotide acetate (1:x) ((with information on acetic acid content)) | Change notification | 08.01.2026 | Production problem | Mytolac 120 mg solution for injection in a pre-filled syringe | |
| Lanreotide acetate (1:x) ((with information on acetic acid content)) | Change notification | 08.01.2026 | Production problem | Mytolac 90 mg solution for injection in a pre-filled syringe | |
| Risperidone | Change notification | 08.01.2026 | Production problem | Risperidone-ratiopharm 25 mg powder and solvent for the preparation of a prolonged-release injection suspension | |
| Risperidone | Change notification | 08.01.2026 | Production problem | Risperidone-ratiopharm 37.5 mg powder and solvent for the preparation of a prolonged-release injection suspension | |
| Risperidone | Change notification | 08.01.2026 | Production problem | Risperidone-ratiopharm 50 mg powder and solvent for the preparation of a depot injection suspension | |
| Sodium (methylprednisolone-21-succinate) | Change notification | 07.01.2026 | Other | Urbason solubile forte 1000 mg | |
| Paliperidone palmitate | Initial report | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 150 mg depot injection suspension in a pre-filled syringe | |
| Paliperidone palmitate | Initial report | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 100 mg Depot injection suspension in a pre-filled syringe | |
| Paliperidone palmitate | Change notification | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 25 mg prolonged-release suspension for injection in a pre-filled syringe | |
| Paliperidone palmitate | Change notification | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 50 mg prolonged-release suspension for injection in a pre-filled syringe | |
| Paliperidone palmitate | Change notification | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 75 mg depot injection suspension in a pre-filled syringe | |
| Albendazole | Initial report | 07.01.2026 | Other | Eskazole | |
| Lamotrigine | Initial report | 07.01.2026 | Other | Lamictal 5 mg tablets for the preparation of an oral suspension or chewable tablets | |
| Disodium pamidronate | Initial report | 07.01.2026 | Production problem | PAMIDRO-cell 3 mg/ml concentrate for solution for infusion | |
| Biperiden hydrochloride | Change notification | 07.01.2026 | Production problem | Biperiden-neuraxpharm 4 mg | |
| Biperiden hydrochloride | Change notification | 07.01.2026 | Production problem | Biperiden-neuraxpharm 2 mg | |
| Galantamine hydrobromide | Change notification | 07.01.2026 | Other | Galantamine-neuraxpharm 8 mg hard capsules, delayed release | |
| Galantamine hydrobromide | Change notification | 07.01.2026 | Other | Galantamine-neuraxpharm 16 mg Hard capsules, delayed release | |
| Galantamine hydrobromide | Change notification | 07.01.2026 | Other | Galantamine-neuraxpharm 24 mg hard capsules, delayed release | |
| Cisatracurium besylate | Change notification | 07.01.2026 | Other | Nimbex 5mg | |
| Doxorubicin hydrochloride | Change notification | 07.01.2026 | Production problem | Doxorubicin hydrochloride Bendalis 2 mg/ml | |
| Fluorouracil | Change notification | 07.01.2026 | Other | Benda-5 FU | |
| Somatostatin acetate | Change notification | 07.01.2026 | Production problem | Somatostatin 3 mg Inresa | |
| Deferasirox | Change notification | 06.01.2026 | Other | Deferasirox Mylan 180 mg film-coated tablets | |
| Tenofovir disoproxil | Change notification | 06.01.2026 | Other | Tenofovir disoproxil Viatris 245 mg film-coated tablets – OP30 | |
| Tenofovir disoproxil | Change notification | 06.01.2026 | Other | Tenofovir disoproxil Mylan 245 mg film-coated tablets – OP90(3×30) | |
| Hydrochlorothiazide; Valsartan | Change notification | 06.01.2026 | Other | VALSARTAN COMP BASICS 160 mg/25 mg film-coated tablets | |
| Hydrochlorothiazide; Valsartan | Change notification | 06.01.2026 | Other | VALSARTAN COMP BASICS 80 mg/12.5 mg film-coated tablets | |
| Hydrochlorothiazide; Valsartan | Change notification | 06.01.2026 | Other | VALSARTAN COMP BASICS 160 mg/12.5 mg film-coated tablets | |
| Beclomethasone dipropionate (Ph.Eur.); formoterol fumarate dihydrate (Ph.Eur.); glycopyrronium bromide (Ph.Eur.) | Initial report | 06.01.2026 | Production problem | Trimbow 87 micrograms/5 micrograms/9 micrograms pressurized gas inhalation, solution – OP360 cans (3×120 cans) | |
| Aprepitant | Change notification | 05.01.2026 | Production problem | Aprepitant beta 125 mg and 80 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 05.01.2026 | Production problem | Atomoxetine beta 80 mg hard capsules | |
| Aprepitant | Change notification | 05.01.2026 | Production problem | Aprepitant beta 80 mg hard capsules | |
| Fluoxetine hydrochloride | Change notification | 05.01.2026 | Other | Fluoxetine beta 20 | |
| Penicillamine | Change notification | 05.01.2026 | Production problem | Metalcaptase 150 mg | |
| Iron(III) hexacyanoferrate(II) | Change notification | 05.01.2026 | Other | Thallium antidote | |
| Rivastigmine hydrogen tartrate | Change notification | 05.01.2026 | Production problem | Rivastigmine Aurobindo 6 mg hard capsules | |
| Insulin lispro | Initial report | 05.01.2026 | Other | Liprolog 200 units/ml solution for injection in pre-filled pen – OP[2x(5x3ml)] | |
| Hydromorphone hydrochloride | Change notification | 05.01.2026 | Other | Hydromorphone HCl PUREN 4 mg hard capsules, delayed release | |
| Escitalopram oxalate | Change notification | 05.01.2026 | Other | Escitalopram Aurobindo 10 mg film-coated tablets | |
| Flucloxacillin sodium 1 H<2>O | Change notification | 05.01.2026 | Production problem | Staphylex 250 mg capsules | |
| Moxifloxacin hydrochloride (Ph.Eur.) ((with information on water content (1:x))) | Change notification | 05.01.2026 | Other | Moxifloxacin Holsten 400 mg film-coated tablets | |
| Insulin lispro | Initial report | 05.01.2026 | Other | Liprolog 100 E/ml KwikPen solution for injection – OP[2x(5x3ml)] | |
| Clomipramine hydrochloride | Change notification | 05.01.2026 | Production problem | Anafranil 75mg retard | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Seroquel Prolong 150 mg prolonged-release tablets | |
| Amlodipine besylate; Perindopril tert-butylamine | Change notification | 05.01.2026 | Production problem | Perindopril/amlodipine Denk 8 mg/5 mg tablets | |
| Gentamicin sulfate | Change notification | 05.01.2026 | Production problem | Gentamicin-POS | |
| Phenylephrine hydrochloride | Change notification | 05.01.2026 | Production problem | Neosynephrine-POS 5% | |
| Minocycline hydrochloride dihydrate (Ph.Eur.) | Change notification | 05.01.2026 | Production problem | Skid 50 mg | |
| Minocycline hydrochloride dihydrate (Ph.Eur.) | Change notification | 05.01.2026 | Production problem | Skid 100 mg | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Quetiapine Hormosan 300 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Quetiapine Hormosan 400 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Quetiapine-Hormosan 200 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Quetiapine-Hormosan 150 mg prolonged-release tablets | |
| Oxycodone hydrochloride (Ph.Eur.) | Change notification | 05.01.2026 | Other | Oxycan uno 10 mg prolonged-release tablets |
| Active ingredients | Status | Update | Specialty |
| alfacalcidol | Stock shortage | 09/01/2026 | Un-Alfa 1 microgram/0.5 ml, IV injectable solution in ampoule |
| methylphenidate (hydrochloride) | Supply tension | 09/01/2026 | Viatris LP Methylphenidate Extended-Release Tablet |
| propranolol hydrochloride | Supply tension | 09/01/2026 | Propranolol-based specialties 40 mg, tablet |
| interferon gamma-1b | Stock shortage | 08/01/2026 | Imukin 2 X 10p6 IU (0.1 mg), injectable solution |
| baclofen | Return to availability | 08/01/2026 | Baclofen Zentiva 10 mg, breakable tablet |
| gemcitabine (hydrochloride) | Stock shortage | 07/01/2026 | Gemcitabine Sun 10 mg/mL, solution for infusion in 120 mL bag |
| fluorouracil | Return to availability | 07/01/2026 | Fluorouracil Accord 50 mg/mL, solution for dilution for infusion, 5 mL, 20 mL, and 100 mL vials |
| methylphenidate (hydrochloride) | Return to availability | 07/01/2026 | Biogaran Methylphenidate, extended-release tablet |
| Varicella-Zoster Virus (VZV) glycoprotein E antigen (recombinant, with adjuvant) ((mammalian/hamster/CHO cells)) | Return to availability | 07/01/2026 | Shingrix, powder and suspension for suspension for injection. Shingles vaccine (recombinant, with adjuvant) |
| risperidone | Stock shortage | 07/01/2026 | Risperidone L.P. 25 mg/2 mL, 37.5 mg/2 mL, and 50 mg/2 mL, powder and solvent for extended-release suspension for injection in a pre-filled syringe |
| risperidone | Return to availability | 07/01/2026 | RisperdalConsta L.P. 25 mg/2 mL, 37.5 mg/2 mL, and 50 mg/2 mL powder and solvent for extended-release suspension for injection in a pre-filled syringe |
| febuxostat hemihydrate | Supply tension | 07/01/2026 | Febuxostat 80 mg, film-coated tablet |
| valproic acid, sodium (valproate) | Supply tension | 06/01/2026 | Micropakine L.P., extended-release granules in single-dose sachets |
| atropine (sulfate) | Marketing discontinuation | 06/01/2026 | Atropine 0,3%, collyre |
| hydroxocobalamin | Supply tension | 05/01/2026 | Cyanokit 5 g, powder for solution for infusion |
| human von Willebrand factor | Supply tension | 05/01/2026 | Wilfactin 100 IU/mL, powder and solvent for solution for injection |
| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| lidocaine hydrochloride | Injection, concentrated | 100 mg/mL | Anticipated | Available | Manufacturing | 9/01/2026 |
| trandolapril | Capsule | 4 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| isoniazid | Tablet, uncoated | 100 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| valsartan~hydrochlorothiazide | Tablet, film coated | 160 mg~12.5 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| temozolomide | Capsule, hard | 20 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| simvastatin~ezetimibe | Tablet | 40 mg~10 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| raloxifene hydrochloride | Tablet, film coated | 60 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| dulaglutide | Injection, solution | 1.5 mg | Resolved | Available | Manufacturing | 9/01/2026 |
| methylphenidate hydrochloride | Capsule, modified release | 60 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| ambrisentan | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| ambrisentan | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| hydrochlorothiazide~olmesartan medoxomil | Tablet | 12.5 mg~40 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| bimatoprost | Eye Drops | .3 mg/mL | Current | Limited Availability | Manufacturing | 9/01/2026 |
| dabigatran etexilate mesilate | Capsule, hard | 172.95 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| paroxetine hydrochloride | Tablet, film coated | 22.22 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| Adalimumab | Injection, solution | 20 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 9/01/2026 |
| gliclazide | Tablet, uncoated | 80 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| estradiol | Drug delivery system, transdermal | .585 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| lamotrigine | Tablet, chewable | 100 mg | Resolved | Available | Manufacturing | 9/01/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| nitrofurantoin | Capsule, hard | 100 mg | Resolved | Available | Unexpected increase in consumer demand | 9/01/2026 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| mupirocin | Ointment | 20 mg/g | Resolved | Available | Manufacturing | 9/01/2026 |
| levodopa~carbidopa monohydrate | Tablet, uncoated | 100 mg~26.9 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| pioglitazone hydrochloride | Tablet, uncoated | 33.06 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| pioglitazone hydrochloride | Tablet, uncoated | 49.59 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| methylphenidate hydrochloride | Capsule, modified release | 20 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| rifampicin | Oral Liquid | 20 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 8/01/2026 |
| baclofen | Tablet, uncoated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 8/01/2026 |
| trandolapril | Capsule | 2 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 555 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| nortriptyline | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 8/01/2026 |
| lamotrigine | Tablet, chewable | 100 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| finasteride | Tablet, film coated | 1 mg | Anticipated | Available | Unexpected increase in consumer demand | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 30.768 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| bisoprolol fumarate | Tablet | 2.5 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| bisoprolol fumarate | Tablet | 10 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| levetiracetam | Tablet, film coated | 500 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| rocuronium bromide | Injection, solution | 50 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| exemestane | Tablet, sugar coated | 25 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| mirtazapine | Tablet, orally disintegrating | 15 mg | Anticipated | Available | Manufacturing | 8/01/2026 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Anticipated | Available | Manufacturing | 8/01/2026 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| enalapril maleate | Tablet | 5 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| enalapril maleate | Tablet | 5 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| quetiapine fumarate | Tablet, modified release | 230.26 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| GluureaLys(ahx)hbedCC | Injection, powder for | 25 microgram | Resolved | Available | Manufacturing | 8/01/2026 |
| GluureaLys(ahx)hbedCC | Injection, powder for | 25 microgram | Resolved | Available | Manufacturing | 8/01/2026 |
| mitomycin | Injection, powder for | 20 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| isoprenaline hydrochloride | Injection, solution | 1 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 8/01/2026 |
| diltiazem hydrochloride | Capsule, modified release | 180 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| diltiazem hydrochloride | Capsule, modified release | 360 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 582.21 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| nizatidine | Capsule, hard | 300 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| galantamine hydrobromide~galantamine | Capsule, modified release | 10.25 mg~8 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| galantamine hydrobromide~galantamine | Capsule, modified release | 20.51 mg~16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| galantamine hydrobromide~galantamine | Capsule, modified release | 30.76 mg~24 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| bethanechol chloride | Tablet, uncoated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 7/01/2026 |
| cyproterone acetate | Tablet, uncoated | 100 mg | Anticipated | Available | Manufacturing | 7/01/2026 |
| paclitaxel | Injection, powder for | 100 mg | Anticipated | Available | Manufacturing | 7/01/2026 |
| cabazitaxel | Injection, concentrated | 60 mg | Current | Limited Availability | Manufacturing | 7/01/2026 |
| rimegepant sulfate | Tablet, orally disintegrating | 85.65 mg | Anticipated | Available | Manufacturing | 7/01/2026 |
| stannous chloride dihydrate | Injection, powder for | 19.2 microgram/mL | Current | Unavailable | Manufacturing | 7/01/2026 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Anticipated | Available | Manufacturing | 7/01/2026 |
| desferrioxamine mesilate | Injection, powder for | 2 g | Current | Limited Availability | Manufacturing | 7/01/2026 |
| etoposide phosphate | Injection, powder for | 1136 mg | Current | Limited Availability | Manufacturing | 7/01/2026 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Resolved | Available | Unexpected increase in consumer demand | 6/01/2026 |
| diclofenac potassium | Oral Liquid, powder for | 50 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 6/01/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 6/01/2026 |
| calcium folinate hydrate | Tablet, uncoated | 18.6 mg | Anticipated | Available | Unexpected increase in consumer demand | 6/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 6/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 6/01/2026 |
| montelukast sodium | Tablet | 10.4 mg | Anticipated | Available | Commercial Changes / Commercial viability | 6/01/2026 |
| pemetrexed disodium | Injection, powder for | 1102.9 mg | Current | Unavailable | Manufacturing | 6/01/2026 |
| Pegvisomant | Injection, powder for | 10 mg | Resolved | Available | Manufacturing | 6/01/2026 |
| topotecan hydrochloride | Injection, concentrated | 4.346 mg | Current | Limited Availability | Unexpected increase in consumer demand | 6/01/2026 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Current | Unavailable | Manufacturing | 6/01/2026 |
| live varicella vaccine | Injection, powder for | 2700 PFU/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 5/01/2026 |
| risperidone | Tablet | 1 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 5/01/2026 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 5/01/2026 |
| iopromide | Injection, solution | 498.72 mg/mL | Resolved | Available | Manufacturing | 5/01/2026 |
| ropivacaine hydrochloride | Injection, solution | 2 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 5/01/2026 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 5/01/2026 |
| pemetrexed disodium | Injection, powder for | 551.4 mg | Current | Limited Availability | Manufacturing | 5/01/2026 |
| linezolid | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 5/01/2026 |
| olmesartan medoxomil~hydrochlorothiazide | Tablet | 40 mg~12.5 mg | Current | Unavailable | Manufacturing | 5/01/2026 |
| sildenafil citrate | Tablet, film coated | 70.24 mg | Current | Unavailable | Commercial Changes / Commercial viability | 5/01/2026 |
| prilocaine hydrochloride | Injection, solution | 100 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 5/01/2026 |
| cefalexin monohydrate | Capsule, hard | 250 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 5/01/2026 |
| Generic Name | Shortage Status | Revision Date |
| Leucovorin Calcium Tablets | Current Shortages | 8-Jan-26 |
| Mometasone Furoate Aerosol for Oral Inhalation | Current Shortages | 8-Jan-26 |
| Mometasone Furoate and Formoterol Fumarate Inhalation Aerosol | Current Shortages | 8-Jan-26 |
| Azithromycin Injection | Current Shortages | 7-Jan-26 |
| Oseltamivir Oral Suspension and Capsules | Current Shortages | 7-Jan-26 |
| Magnesium Sulfate Injection | Current Shortages | 6-Jan-26 |
| Megestrol Acetate Tablets | Current Shortages | 6-Jan-26 |
| Phenytoin Oral Suspension | Resolved Shortages | 6-Jan-26 |
| Ropivacaine Injection | Current Shortages | 6-Jan-26 |
| Ketamine Injection | Current Shortages | 5-Jan-26 |
| Linezolid Injection | Current Shortages | 5-Jan-26 |
| Methotrexate Injection | Current Shortages | 5-Jan-26 |
| Metoprolol Injection | Current Shortages | 5-Jan-26 |
| Pantoprazole Injection | Current Shortages | 5-Jan-26 |
| Theophylline 24-Hour Extended Release Capsules and Tablets | Current Shortages | 5-Jan-26 |
January 09, 2026
January 08, 2026
January 06, 2026
January 05, 2026
January 09, 2026
January 08, 2026
January 06, 2026
January 05, 2026
